INCIDENCE AND RISK FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE (cGVHD) AFTER CORD BLOOD TRANSPLANTATION (CBT)

被引:0
|
作者
Saliba, R. M. [1 ]
Couriel, D. [2 ]
Komanduri, K. [1 ]
Patah, P. [3 ]
Westin, J. [1 ]
Giralt, S. [1 ]
Cooper, L. [1 ]
Petropoulos, D. [1 ]
Worth, L. [1 ]
Safdar, A. [1 ]
Champlin, R. E. [1 ]
Shpall, E. J. [1 ]
de Lima, M. [1 ]
机构
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Tennesse Oncol, Nashville, TN USA
[3] Hosp Sirio Libanes, Sao Paulo, Brazil
关键词
D O I
10.1016/j.bbmt.2007.12.372
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
362
引用
收藏
页码:132 / 133
页数:2
相关论文
共 50 条
  • [41] Acute graft-versus-host disease and cord blood source are risk factors for Clostridium difficile infection after allogeneic stem cell transplantation
    Willems, L.
    de latour, R. Peffault
    Porcher, R.
    Lafaurie, M.
    Cazin, I.
    Robin, M.
    Rocha, V.
    Devergie, A.
    Socie, G.
    Ribaud, P.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S63 - S63
  • [42] INCIDENCE AND RISK FACTORS OF GRAFT-VERSUS-HOST DISEASE AFTER LIVER TRANSPLANTATION: A NATIONAL STUDY 2010-2020
    Huang, Yuting
    Wang, Yichen
    Yang, Liu
    HEPATOLOGY, 2023, 78 : S321 - S322
  • [43] Incidence and risk factors of graft-versus-host disease after liver transplantation: A national study 2010-2020
    Huang, Yuting
    Wang, Yichen
    Chase, R. Christopher
    Yang, Liu
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (10)
  • [44] Risk factors for extensive chronic graft-versus-host disease (cGvHD) after allogeneic stem cell transplantation (Allo-SCT): prospective evaluation of 165 patients
    Varettoni, M
    Bernasconi, P
    Colombo, AA
    Caldera, D
    Malcovati, L
    Mangiacavalli, S
    Troletti, D
    Rumi, E
    Pascutto, C
    Lazzarino, M
    Alessandrino, EP
    BONE MARROW TRANSPLANTATION, 2002, 29 : S171 - S171
  • [45] Weight loss in pediatric patients with chronic graft-versus-host disease (cGVHD)
    Browning, B
    Thormann, K
    Tse, W
    Duerst, R
    Kletzel, M
    Jacobsohn, DA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 71 - 71
  • [46] Histopathological and Electrophysiological Findings in Musculoskeletal Chronic Graft-Versus-Host Disease (cGVHD)
    Sekiguchi, Kenji
    Kanda, Fumio
    Yasui, Naoko
    Kanzawa, Maki
    Kowa, Hisatomo
    Nishino, Ichizo
    Toda, Tatsushi
    NEUROLOGY, 2013, 80
  • [47] SKIN SCLEROSIS IN CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) - COMPARISON WITH SCLERODERMA
    JANINMERCIER, A
    DEVERGIE, A
    VANCAUWENBERG, D
    BOURGES, M
    LAPIERE, CM
    GLUCKMAN, E
    PATHOLOGY RESEARCH AND PRACTICE, 1983, 178 (02) : 134 - 134
  • [48] Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT)
    Okoev, Grigori
    Weisdorf, Daniel J.
    Wagner, John E.
    Blazar, Bruce R.
    MacMillan, Margaret L.
    DeFor, Todd E.
    Lazaryan, Aleksandr
    El Jurdi, Najla H.
    Holtan, Shernan
    Brunstein, Claudio G.
    Betts, Brian C.
    Takahashi, Takuto
    Bachanova, Veronika
    Warlick, Erica D.
    Rashidi, Armin
    Arora, Mukta
    BLOOD, 2019, 134
  • [49] Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation
    Przepiorka, D
    Petropoulos, D
    Mullen, CA
    Danielson, M
    Mattewada, V
    Chan, KW
    BONE MARROW TRANSPLANTATION, 1999, 23 (12) : 1291 - 1295
  • [50] A Phase I/2 Study of Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis after Allogeneic Transplantation (alloHCT)
    Chhabra, Saurabh
    Hari, Parameswaran
    Visotcky, Alexis
    Zhu, Fenlu
    Cantrall, Kassandra
    Abedin, Sameem
    Dhakal, Binod
    D'Souza, Anita
    Drobyski, William R.
    Fenske, Timothy S.
    Jerkins, James
    Rizzo, J. Douglas
    Runaas, Lyndsey
    Saber, Wael
    Shah, Nirav N.
    Shaw, Bronwen E.
    Pasquini, Marcelo C.
    Hamadani, Mehdi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)